The Role of the P2Y12 Receptor in Tissue Factor Induced Coagulation.

Trial Profile

The Role of the P2Y12 Receptor in Tissue Factor Induced Coagulation.

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Nov 2012

At a glance

  • Drugs Prasugrel (Primary)
  • Indications Thrombosis
  • Focus Pharmacodynamics
  • Most Recent Events

    • 13 Dec 2011 Results presented at the 53rd Annual Meeting and Exposition of the American Society of Hematology.
    • 08 Jul 2011 Actual end date (Nov 2010) added as reported by ClinicalTrials.gov.
    • 08 Jul 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top